Feasibility Study for Enhancing Gait Following Stroke With Implanted Microstimulators

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-05-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test an innovative, advanced FNS microstimulator technology developed by the Alfred Mann Foundation (Santa Clarita, CA) called, the Radio Frequency Microstimulation (RFM) Gait System that promises to provide FNS training for restoration of functional gait components in a manner at least as efficacious as current investigational FNS systems. The design features of the RFM Gait System are intended to address the problems with the current FNS systems. The RFM implant devices are small enough to be inserted using only a 5 mm incision\[3\]. Because both the electrode (anode and cathode) are contained within the microstimulator, there are no lead wires traversing the skin, joints, or torso/limb junctures. Individual RFMs can be inserted at the motor points and nerves of each of the paretic muscles in the involved limb and coordinated using radio frequency technology.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008

NCT00864708

Stroke

TERMINATED NA

Clinical Implementation of Multichannel Functional Electrical Stimulation Device for Gait Rehabilitation in Subchronic Stroke: A Feasibility Study

NCT07211672

Stroke Sequelae Stroke ( 3 Months After Onset)

NOT_YET_RECRUITING NA

Effectiveness of Multichannel Functional Electrical Stimulation

NCT04876703

Stroke Hemiparesis

UNKNOWN NA

Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke

NCT00142792

Stroke, Acute Stroke Hemiparesis

COMPLETED NA

Implant for Walking After Stroke

NCT05740540

Stroke Hemiplegia Gait, Hemiplegic

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective (Aim I) of this study is to evaluate whether the RFM Gait System can restore the capability to perform the components of gait required for safe, functional walking, for patients in the chronic phase after stroke (\> 12 months). We will assess the treatment provided by the RFM system at the Cleveland VA compared to the FNS percutaneous Schreiner electrodes and custom-designed controller previously investigated by the investigators.

The similarities between the RFM-based and percutaneous FNS systems will be assessed using six gait components required for the execution of functional, safe gait, which are lower limb strength, coordination, an index of walking endurance, muscle tone, walking speed, and quality of life.

The secondary objective of this study is to test the technological performance and safety of the RFM Gait System. Measures of technology performance and safety include implantation time; anchoring capability at the motor point of the muscle; reliability of the RFMs during use; reliability of electrical performance of the system; comfort of the system (with stimulation off); comfort of the electrical stimulus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiparesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Implanted

All participants.

Group Type EXPERIMENTAL

Radio-frequency Microstiumulator

Intervention Type DEVICE

All participants will receive leg implants and will be trained first in the clinical and subsequently perform stimulation-assisted exercises in the home - for an overall duration of 6 months post-implant. Subsequently, exercise programs will continue without stimulation. Patient condition will be assessed at 9, 12 and 24 months post-implant.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radio-frequency Microstiumulator

All participants will receive leg implants and will be trained first in the clinical and subsequently perform stimulation-assisted exercises in the home - for an overall duration of 6 months post-implant. Subsequently, exercise programs will continue without stimulation. Patient condition will be assessed at 9, 12 and 24 months post-implant.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

The specific device name is the Radio Frequency Microstiumlator (RFM) System.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Cognition intact to give valid informed consent to participate.
2. Sufficient endurance to participate in rehabilitation sessions.
3. Ability to follow 2 stage commands, in English.
4. Medically stable.
5. Age \> 21 years.
6. Impaired ambulation as follows: inability to flex the knee and ankle in the sagittal plane, in a normal manner so the foot clears the floor, inability to control normal knee angle during single limb weight bearing during stance phase .
7. Minimum trace (Manual Muscle Test score of 1) contraction of hip, knee, and ankle flexors and extensors under volitional control.
8. Passive range of motion at hip, knee, ankle normal gait kinematics.
9. Five degrees (5°) of motion for knee and ankle flexors and extensors produced by muscle stimulation achieved non-invasively with electrical stimulation applied to the skin surface.
10. At least 12 months post stroke.
11. Ability to understand the informed consent form in English.
12. Thigh and lower leg circumference and length ≤ 50th percentile of standard U.S. population morphology measures.\*
13. Participants should be able to walk and keep balance without physical assistance
14. Response to Surface Stimulation at a trace for tibialis anterior and peronous longus.
15. Subject with unilateral defects

Exclusion Criteria

1. Acute or progressive cardiac, renal, respiratory, neurological disorders or malignancy.
2. Active psychiatric diagnosis or psychological condition, or active drug/alcohol abuse.
3. Lower motor neuron damage or radiculopathy.
4. More than one stroke.
5. Allergy or contraindication to the anesthesia, Versed, (or comparable substitute).

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No